2-Amino-6-et hynyl-4-n-pentyloxy-pteridine afforded with ethyl p-iodobenzoyl-glu tamate in a second Heck reaction and subsequent alkaline hydrolysis a new fo lic acid analogue.
In another series of reacti o ns we investigated the hyd ration of the various alkynyl groups by water addition in TFA and in the presence of HgO. 2-Amino-6-ethynyl-4-n-pentyloxy-pteridine afforded under these conditions an attack at the a-C-atom of the side-chain with formation of the 6-acetyl derivative whereas the corresponding 6-methyl-and 6-phenylethynyl compounds revealed an opposite addition a t the I3-C-ato m. Fine-structural studies by UV and NMR spectra showed that 2-amino-6-acetonyl-and 2-amino-6-phenacetyl-4-n-pentyloxy-pteridine respectively exist in solution as a tautomeric mixture of the keto-and the vin ylogo us amide form . The latter tautomer seems to be the thermodynamically more stable a rrangement which is formed in excess from the phenacetyl deri vative in acetonitrile in a relatively slow reaction. It was furtherm o re found that both tautomers can be separated by HPLC and isolated in pure form indicating an unusual high barrier of acti vation between these two species. A time-dependent study of the UVspectra in MeOH or buffer pH 8 reveals a slow con-\er~ion from both sides to the same equilibrium mixlure. These findings have so far not been observed in the pteridine series and seem to be unique also from a theoretical point of view. Lumazine-6-and 7-Carboxylic Acids W. Pfleiderer and R. Eisele
Fakultiit fur Chemic, Universitiit Konstanz, 0-77S0 Konstanz, Germany
The lack of information about lumazine carboxylic acids [1, 2] forced us to investiga te more systematically the chemical and physical properties of this type of compounds. The synthesis of lumazine-6-and 7-earboxylic acid was achieved either by permanganate oxidation of 6-and 7-methyllumazine or by acid hydrolysis of pterin-6-and 7-carboxylic acid, respectively. Treatment by methanol/ HCl afforded esterification and subsequent ammonolysis led to the corresponding carboxamides. Methylation of lumazine-6-carboxylic acid by dimethylsulphate in alkaline medium gave a mixture of the 1.3-and 3.8-dimethyl derivatives whereas the quarternization by dimethylsulphate in OMF I AeOH afforded the 8-methyl-lumazine-6-carboxylic acid in good yield. Permanganate oxidation of 6.7-dimethyllumazine gave rise to 6-methyl-lumazine-7-carboxylic acid and the isomeric 7-methyl-lumazine-6-carboxylic acid resulted from a Timmis condensation between 6-amino-2-methylthio-S-nitroso-Spyrimidone and ethyl acetoacetate and followed by an acid eatalysed hydrolysis. The syntheses of lumazine-6. 7 -diearboxylic acid and its 1-and 3-monomethyl as well as the 1.3-dimethyl derivative were best performed by a Gabriel-Isay reaction condensing the appropriate S.6-diaminouracil with dimethyl 2.3-diketosuccinate. The latter carbonyl component reacted with 6-methylamino-S-amino-uracil to dimethyl 7-hydroxy-8-methyl-7 .8-dihydrolumazine-6. 7-dicarboxylate which can be regarded as a stable covalent hydrate of dimethyl 8-methyllumazine-6.7-dicarboxylate. The presence of three adjacent bulky substituents at the pyrazine moiety is unfavoured from steric reasons and water addition to the quinonoid IT-electron system causes some release from internal strain. Catalytic reduction of the lumazine carboxylic acids and their derivatives procccd in the normal manner to the S.6.7.8-tetrahydro derivatives which oxidize easily as neutral species but arc much more stable towards autoxidation as cations and show complete stability in form of their N-S acyl derivatives. Dimethyl 1.3-dimethyllumazine-6. 7 -dicarboxylate has either been reduced catalytically to its tetrahydro form or by lithium borohydride to the corresponding 7,8-dihydro derivative. The former product forms with acetic anhydride the S-acetyl-and the S.8-diacetyl derivative whereas the latter gave rise to the formation of dimethyl S.8-diacetyl-S .8-dihydro-1. 3-dimethyllumazine-6.7-dicarboxylate. This unexpected structure can be seen as a consequence of the steric crowding of the pteridine nucleus by the various types of substituents.
The newly synthesized compounds have been characterized by their UV spectra and their acidic pK values. From this data can been seen that the lumazine-7-carboxylic acids are stronger acids than their 6-isomers and there is also a more pronounced electronic interaction of the carboxyl function in the 7-over the 6-series. The presence of a carboxyl, ester or carboxamide group in 6-and/ or 7-position induces a distinct difference in N-H acidity at the pyrimidine moiety which has not been observed in lumazine itself. The acidities of the carboxyl groups in the lumazine-6.7 -dicarboxylic acids are relative close to each other and have been found at 1.0 and 3.3 respectively.
The tetrahydro derivatives revealed the expected properties which relate directly to the more simple S.6.7 .8-tetrahydrolumazines and their S-acyl derivatives [3] .
peculiar reactivity emphasized by the covalent hydration and the low solulibility in most protic and especially aprotic solvents . We found an indirect route to synthesize 6-thioxanthopterin from 2-amino-6-chloro-4-n-pentyloxypteridine which reacted with sodium hydrogensulfide to form 2-amino-4-n-pentyloxy-6-pteridinethione and followed by subsequent base-catalysed hydrolysis. Methylation led to 6-melhylthiopterin and permanganate oxidation afforded the pterin-6-sulfonic acid.
Fine-structural features of the 6-thioxanthopterin can be recognized from the basic and acidic properties as well as the UV jVIS spectra in comparison to xanthopterin. Thiation causes a decrease in basicity and consequently also an increase in acidity by about 1.5 pK units. The absorption spectra of the various molecular spccics reveal a general bathochromic shift of the long wavelength absorption band in the thio derivative which adapts in aqueous solution mainly the thione rather than the thiol configuration. Monoanion formation is associated with a pronounccd hypsochromic shift of the spectrum typical for the ionization of the thioamide function. There is no or very little covalent hydration in 6-thioxanthopterin indicating a less distinct rr-clcctron-deficicncy in the pyra7:inethione moiety. Time depcndent UV spectra in methanol show a strong decreasc of the long wavelength absorption band in xanthopterin whereas no effect has been recognized in the 6-thioxo analog.
The oxidation of 6-thioxanthoptcrin to pterin-6-sulfonic acid has now given proof to the structure of the latter compound which has been obtained already in 1959 by Viscontini and Weilenmann [1] on treatment of tetrahydropterin with SO~ and subsequent air oxidation whereas the alternative proposal favouring a xanthopterinsulfate structure [2, 3] can be discarded . [2] . We have synthesi7:ed some modified neopterin derivates carrying instead of the NH-function in 2-position a sulfur linkage which will allow the development of a new and potentially more selective assay. All of the so far described modified neopterins for the development of bioassays are substituted at the 2-amino-group by (J)-carboxy or ())-aminoalkylchains of variable length (1) . The reactive terminal functionalities of these molecules are necessary for the coupling to different proteins.
Formally the newly described molecules are derived from the not yet synthezised D-erythro-2-thioneolumazin. Our approach to the S-substituted 2-thioneolumazine derivatives (2) , however started from modified pyrimidines 0) . The first reaction was the nitrosation of the heterocycle in 5-position in a well known reaction by sodium nitrite and acetic acid.
0)
II NaN(h/C! h('(Xlll 2)(Nll,);S, .
3) D-Ar.Jbin05e-phcnylh ydrazon (;I.) Reduction of the nitrosofunction worked well with ammoniumpolysulfide and resulted in the formation of the corresponding 5.6-diaminoderivatives which have been used as building blocks in the subsequent condensation reaction with the D-arabinose-phcnylhydrazone in a well known manner. The condensation reactions resulted in the formation of various tricyclic pyrano[3.2-g] ptcridincs, a new type of intermediary pteridines, first reported by Soyka and Pfleiderer [3] . The last step of the reaction sequence is the mild oxidation of the formal 5,6-dihydropteridine-adducts (4) by p-benzochinon in aquous solution to the S-«())-Carboxyalkyl)-2-thioneolumazines CD proceeding in high yield. The UV-and the IH-NMR-spectra of the newly synthezised compounds have been discussed and proved the anticipated structures. It has been found that pyrimidodiazepine (acctylhomopterin) and 2.4-diamino-6,7-diisopropyl pteridine reduced the activity by 50'/'0 at the concentration of 0.1 mM. Among the neurotransmitter substances and their percursors tested , melatonin (3 m M) and Nacetylserotonin (3 mM) caused the complete inhibition of the enzyme activity. Experiments are currently underway for searching sepiapterin reductase deficient mutant to investigate the regulations involved in the biosynthesis of tetra hydro biopterin in Drosophila.
New catalytic functions of human carbonyl and aldose reductase in tetrahydrobiopterin biosynthesis arc proposed. During purification of sepiapterin reductase from human brain an enzyme was obtained which used sepiapterin as a substrate but was distinct from classical sepiapterin reductase (EC 1.1.1.153) in molecular weight. The enzyme was identified as carbonyl reductase by using immunoblot assay. The activity of carbonyl reductase to reduce sepiapterin was one thousand fold lower than the known activity of rat erythrocyte sepiapterin reductase. However, antibodies against carbonyl reductase inhibited sepiapterin reduction in human brain extract more than 30% , indicating that carbonyl reductase significantly contributes to the tota l sepiapterin reductase activity of human brain . These findings led us to test for a catalytic function of carbonyl reductase with PPH 4 .
In the presence of enzymatic oxygen depleting sys tem two major peaks of enzymatic products were found by HPLC. These two peaks were identified as LPH~ and 2' -oxo-PH 4 by comparison with standard tetrahydro pterins. The identit y of both compounds were further verified by their con ve rsion to BH 4 after incubation with sepiapterin reductase. AT 5 mM of Nace tyl serotonin. a concentration which completely inhibitcs rat sepiapterin reductase. carbonyl reductase was still 80% active.
Aldose reducta se, which has been known only to conve rt PPH 4 to LPH 4 • also catalyzed the reduction of 2' -OXO-PH 4 to BH 4 .
Based on these results two alternative pathwa ys converting PPH 4 to BH4 in the genetic deficie ncy of sepiapterin reducta se are proposed. In th e case of a muta tion with residual acti vity in sepiaptcrin reductase. the combined activitics of carbonyl reductase and aldose reductasc would fully compensate the decreascd activity of sepiapterin reductase. Because the production of 2'-oxo-PHcI by carbonyl reductase is much lower than by sepiapterin reductase. th e significance of the alternative pathway ill rim in the case of sepiapterin reductase deficiency is difficult to estimate . However, the operation o f the pathway in vivo was demonstrated by incubation of aldose reductase with the reaction mixture of ca rbon yl reduct ase. The carbinolamine dehydratase catal yzes the dehydration of the 4a -carbinolamine to form quinonoiddihydropterin in the phenylalanine-hydro xylase-catalyzed reaction .
A new procedure that permits simultaneously purification of phen yla lanine hydroxylase and earbinolamine dehydratase from the sa me liver extract is desc ribed . The carbinolamine dehydratase was purified from rat and human liver with 12 % and 26% recovery, respectively. The homogeno us enzymes revealed a subunit Mr of 12999. The Mr of native enzyme was 50000 as determined by gel filtration of Sephacryll S-200 HR column. No difference in the Mr of purified earbinolamine dehydratase from rat and human liver can be detected .
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The spectral evidence for the formation of an intermediate product during hydroxylation reaction was st udied unde r different conditions: pH values around 8.4 and 6.8. the use of purified enzymes from human li ve r. and. in the absence or presence of carbinol amine dehydrata se. A close correlation was observed between the amount of tyrosine and 4a-carbinolamine formed in the human phenyla lanine-hydroxylase-cata lyzed reacti o n. [1] . Biochemically this deficiency causes accumulation of quinonoid dihydrobiopterin , which readily rearranges to BH2 and 7,8-dihydropterin (PH2) [2] . The aim of this study was to investigate whether these pterins can inhibit aromatic amino acid model enzyme, its activity being determined by the rate of tyrosine formation.
Phenylalanine hydroxylase is activated by phenylalanine (Phe) and /or phosphorylation, a process shown to be inhibited by BH4 and BH2 [3] .
The Km (Phe activated enzyme) for BH4 was found to be 13 j.lM . Inhibitor studies revealed that BH2 was a competitive inhibitor, with respect to BH4. A Ki of 25 ~tM was obtained when BH2 was added during Phe activation . In contrast, addition of BH2 following Phe acti vation produced a Ki of 150 j.lM. PH2 was shown only to be a weak inhibitor of this enzyme, with similar inhibitor constants when added either during Phe activation (214 j.lM) or after activation (200 j.lM).
Accumulation of BH2 in DHPR deficiency may contribute to impaired Phe hydroxylation by (a) inhibiting activation of Phe hydroxylase and (b) competitively inhibiting the native form of this enzyme. 
Folate catabolism is thought to occur primarily in the stomach and the upper duodenum. This process ultimately leads to a lowered bioavailability of folate species into the body compartment for utilisation as a vitamin. The oxidant nitrite has been found to be a potent agent in facilitating folate breakdown invitro at acid pH . Similarly the effects of nitrite on folate bioavailability in-vivo was assessed.
Six healthy persons were administered 10 mg 5methyltetrahydrofolate after ingesting a standard breakfast. Blood samples were taken at 0 and 3 hours. Plasma 5MeTHF was measured as outlined in the abstract 'Food Folates and the British Total Diet Study' . In addition to the control experiment 5MeTH F was administered in conjunction with a 5 and 50 molar excess of nitrite. Significantly lower plasma folates were observed after the administration of nitrite (39.6% of control value with 5 fold excess, 27 .7% of control value with 50 fold excess).
Studies by McNulty et a1. (1987) suggest that approximately 100 j.lg daily folate is eatabolised per person (as measured by the identification of urinary scission products). From folate measured in the British Total Diet Study folate intake was estimated to be 130 !lgjday. Therefore 100/130 x 100 = 76.9% of daily folate is catabo!ised per person. This leaves 23.1 ' Yo folate intact. The value compares well to the lower figure calculated from the above human data where physiological ratios of nitrite to folate were examined.
The main site of catabolism is thought to be the stomach where in particular nitrite acts upon folate to reduce bioavailability. From the data presented, there appears a discrepancy between folate ingested and folate made available to the body. The recommended daily allowance (RDA) is a measure of folate intake in ingested food and should be distinguished from recommended daily uptake (RDU) which is a measure of first pass folate entering the body. The term RDU might prove valuable in that it accounts for naturally occurring oxidation processes which render reducted folates less available for utilisation as a vitamin. The Action of Nitrite on Tetrahydrofolates G. Farrar ' ), J. A. Blair ' ), R. Leeming
Nitrite is a potent oxidant and is widely distributed in the environment. In addition saliva contains nitrate reducing bacteria; coupled with food nitrites the daily intake is thought to be approximately 1 mg. This represents an approximate SO -ISO fold molar excess of nitrite over folate. The effects of nitrite on reduced folates in-vitro have been studied.
In acid media only (pH 2.3) nitrite rapidly oxidised Smethyltetrahydrofolate (SMeTH F) . No fluorescing products were formed. Equimolar levels of antioxidants (ascorbate, uric acid, bovine serum albumin) did not protect against nitrite mediated SMeTHF breakdown at pH 2.3. Using radiolabelled 14(C)-SMeTHF, a novel non-folate species was identified when SMeTHF was subjected to nitrite in acid media. UV / visible scanning spectrometry revealed a shift from 300 nm to 267 nm in the new product. Folic acid was not susceptible to oxidative breakdown by ni trite. Sand 10 rormyltetrahydrorolates undergo cyclisation to S,10methenyltetrahydrofolates at acid pH. Although this species can be detected by fluorescing HPLC the signal is approximately 100 times less intense than that of SMeTH F. When S,l Omethenyltetrahydrofolate was subjected to nitrite, a novel species was formed over two hours with a 12 fold increase in tlourescing intensity. Comparative UV /visible and fluorescing spectrometry revealed this species to be the oxidised 10-formyfolie acid. Since this novel species is 12 times as sensitive to detection than S, 1 Omethenyltetrahydrofolate, an HPLC analysis for the detection of formyl folates based on the cylisation-oxidation reaction is being developed.
The results indicate that reduced tetrahydrofolates, in particular 5MeTHF are susceptible to breakdown by nitrite. This reaction may have serious consequences in-vivo because in the case of 5MeTHF (the most predominant folate) non-folate species are formed. 
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The British Total Diet is representative of the normal daily diet of the average Briton . The diet is divided into 20 food groups (c. g. bread, cereals, meat, fruit etc.) covering all aspects of anticipated daily intake. The study was set up in the 1960's to monitor for pesticide contamination and analyse heavy metals. Food samples have been available at 2 week intervals from randomly selected towns throughout Great Britain. A measurement or folate content in the total diet study was undertaken to quantify folate content in the daily diet. The sum of folate levels in each of the 20 food groups should equate to the daily intake or folate. This value should also approximate with rolate recommended daily allowance (RDA).
Smethyltetrahydrofolate (SMeTHF) is the most prominent folate species in foodstuffs and can be measured by HPLC (by fluorescence detection) using a S ~lm, 25 cm reverse phase column with a solvent of 8 -10°/r> acetonitrile, pH 2.3. A 40% (w/ v) homogenate (in 2% ascorbate in distilled water) was prepared and centrifuged at 100 G for 1 hour. The supernatants were analysed for SMeTHF by HPLC. Samples were measured pre and post treatment with chicken pancreas conjugase to measure monoglutamate and total folate.
The monoglutamate total for six randomly selectcd towns was 7S.S7 Ilg/day (± 3S.84 S.D), whilst total Smcthylfolate was 130.74 ~lg i day (± 21.68). We believe that the values are a good representation of the daily intake of methyl folates since measurements were taken post harvesting, storage and cooking. Measurement of formyl folates by HPLC (possibly counting for up to 10% of total folates) is being currently investigated. inducers of pteridine synthesis in both human and murine fibroblasts. In our contribution we summarize the knowledge of the mechanism how cytokines stimulate pteridine synthesis. 6-Pyruvoyl tetrahydroplerin synthase and sepiapterin reductase activities are consistently present in the cells and remain unchanged by the cytokine treatment. Irrespective of the ratio of neopterin to biopterin derivatives formed, cytokines cause a dose-and time-dependent increase in guanosine 5'-triphosphate (GTP)-eyclohydrolase I (EC 3.5.4.16) activity, which ranges from two-to hundered-fold as compered to untreated controls. Murine maerophages contain hig h GTP-cyclohydrolase I activity already when untreated, and this is only marginally stimulated by cytokines. Since this activity is measured at saturating conditions of GTP in absence of other cellular low molecular weight compounds, the increases observed reflect true biosynthetic activity rather than feedback or substrate concentration effect s. GTP-cyclohydrolase r activity takes 30 hours to reach its maximum, and this increase in activity is inhibited by cyclo-hexamide. A polyclonal antiserum to murine liver GTP-cyclohydrolase J docs not stain human or murine cell extracts with high GTP-cyclohydrolase I activity in Western blots, but does readily cross react with human liver homogenates. These results suggest that the mechani sm of stimulation of pteridine synthesis by cytokines is a de novo synthesis of GTP-cycloh ydrola se I protein, which in its antigenic properties differs from the liver form of GTPcyclohydrolase I. Treatment of murine fibriblasts, isolated from ear dermis of adult Balb/c mice, with interferon-y (IFNy) in combination with tumour necrosis factor-a (TNF-a) enhances GTP-cyclohydrolase I activity about 40-fold leading to increased intracellular tetrah ydrobiopterin (BH 4 ) concentrations. In parallel these cells form nitric oxide, nitrite and nitrate from L-arginine. After 96 hours of incubation with IFN-y/ TNF-a a 50% decrease in cell viability can be observed. This cytotoxic effect of IFN-yjTNF-a is reduced by N(i-monomethyl-L-arginine (NMA), an inhibitor of nitrogen oxide formation from L-arginine and it is restored by simultaneous addition of 10 mM L-arginine but not by D-arginine. Further, IFN-yj TNF-a is not toxic in arginine-deficient culture medium . thu s demon stra ting that the observed cytotoxic effects are linked to nitrogen oxide formation . Nitrite pro duction is inhibited by 70% by 2,4-diamino-6-hydroxyp yrimidine (OAHP), an inhibitor of GTPcyclohydrolase I, which leads to impaired tetrahydrobiopterin (BH 4 ) production. Nitrite production is restored by concomittant treatment with sepiapterin , but not with isoxanthopterin or pterin-6-earboxylic acid. In paralIel, cytotoxicity of IFN-yjTNF-a is reduced by OAHP and again augmented by OAHP plus sepiapterin. Our data thus indicate that in murine fibroblast s formation of nitrogen oxides and the related cytotoxic effect of cytokiens is controlled by intracellular BH4 levels. The kynurenine level of blood serum and urine without and after L-tryptophan load in a n oral dose of 30 mg/ kg of bod y weight has been determined in 10 h ealthy subjects and 102 patients with different forms o f chronic glomerulonephritis. The increased accumulation of kynurenine both in serum and urine has only been observed in patients suffering from mesangial-proliferative glomerulonephritis with proteinuria less t han 2 gj 24 h. Normal concentration (mean ± Neopterin screening and measurement is a useful and innovative tool lor the biochemical monitoring of a variety of disease states. As an alternative to urine and serum measurement, whole blood (obtained by lInger or car-stick) spotted on filter paper prese nts a convenient specimen for screening where convenience a nd confidentiality of donor compliance (i. e., repetitive sampling, personal sampling and mail out) are preferable. We have d eveloped a rapid (3 hour) RIA test for neopterin measurement in whole blood spotted on filter paper. Using this assay and a sensitive serum RIA test originally developed by us under NIH grant, preliminary studies on 27 apparently hea lthy la b workers displayed ranges of 1.27 ± 1.0 ng/ ml, 2.2 ± 1.6 ng!ml and 3.2 ± 1.3 ngj ml for plasma, serum
Modulation of Cytokine
and whole blood neopterin levels, respectively. Whole blood neopterin levels were 12.8 ± 5 ngjml whole blood in 30 (1 -3 day) neonates without obvious genetic disorders. The assays described are highly specific for D-erythroneopterin. The higher levels see n in whole blood versus serum may be attributed to neopterin released from the "cellular" compartment during elution. This difference and that observed between serum and plasma remain to be elucidated . Tetrahydrobiopterin is the cofactor of phenylala nine, tyros ine and trypt o pha n hydroxy lases; it furthermore might have an immun o logical role as modulator of immune system activation [1] . Previous reports [2, 3] proposed that human milk biopterin (B) could be responsible for milder hyoerphen ylalaninemia occurring in breast fed patients affected by malignant phenylketonuria. We assessed pteridines in milk samples by 40 women who delivered at different gestational ages by HPLC method. In our samples B amounts were constantly higher than N ones and both of them were constant as measured in samples by the same woman. There was a statistically significant difference between B concentrations in milk by women who delivered prematurel y and those over the 3~Hh week of gestation (p 0.01). We do not think B content is sufficient to control plasma phenylalanine levels in tetrahydrobiopterin deficient patients; in contrast, it mi ght be implicated in events occurring in Immune system activation in gastrointestinal tract. Concentrations of neopterin and interleukin-6 (lL-6) were measured in sera from 44 subjects (12 male, 32 female, median age 71 years, interquartile range 63 to 75 years) suffering from multiple myeloma. In addition , multiple clinical and laboratory variables were concomitantly determined. The patients were followed up for 9 yea rs , and the abilities of all variables to predict outcome was assessed . Median neopterin was 12.25 nmol / I , Cinterquartile range 7.3 to 24.9 nmol/ I); median IL-6 was 3 pg/ml (1.3 to 7.0 pg/ ml). Both IL-6 (Kruskal-Wallis H statistic = 6.83, P = 0.033) and neo pterin concentrations (N = 14.15, P = 0.0008) were significantly higher in higher stages of the disease . The correlations between neopterin and IL-6 was weak, however significant (Spearman's rank correlation coefficient Rs = 0.38, P = 0.019). stage (P = 0.0009), creatinine (P = 0.011), WHO class (P = 0.014) and IL-6 (P = 0.025) as significant predictors of survival. If the variables, in contrast, were dichotomized (only two groups per variable), the results remained similar (for IL-6, 7 pgj ml was found to be the optimal cut-off value; for neopterin, the observed median of 12.25 nmol /I was employed): neopterin (P = 0.0001), stage T vs II / IJI (P = 0.0002) and IL-6 (P = 0 .0029).
Multivariate Cox analysis showed that either neopterin (joint significance P = 0.0050) and stage (P = 0.0048) or neopterin (P = 0 .0001) and TL-6 (P = 0.053) are useful combinations of predictors, but IL-6, which is supposed to influence tumor cell proliferation in an autocrine manner, failed to contribute significantly to prediction of stage is included in a model. In conclusion, neopterin proved to be the best single predictor, and it is a statistically independent predictor, suggesting that other eytokines as, e. g., interferon-gamma, also affect the progression of the malignant disease . We measured neopterin and ferritin concentrations in the serum of 74 patients suffering from haematological neoplasias -with the exception of 11 patients who had solid tumours (n = 9) or unknown diagnosis (n = 2). The remaining 63 patients had the following diagnoses: Non-Hodgin's lymphoma (NHL) (n = 42), Hodgkin's disease (n = 11), monoclonal gammopathy of unknown significance (M GUS) or plasma cell myeloma (n = 9) and myelodysplastic syndrome (n = 1). In 54/74 patients (73 cit,) additional parameters (haemoglobin, serum iron) were available. In some patients we performed serial measurements of neopterin, ferritin and haemoglobin concentrations (total values = 119). Follow-up of patients during successful therapy revealed decreasing and sometimes normalizing neopterin and ferritin concentrations whereas haemoglobin levels increased.
Association between Serum Neopterin and Ferritin in
Our results confirm the hypothesis of an association between the degree of activation of macro phages as it is indicated by increased neopterin levels and the development of anaemia by a shift of iron towards the storage sites. Since the early 1970s, second look surgery has played a central part in studies of chemotherapy and radiation treatment for ovarian cancer of an advanced stage. However, the benefit of surgical reexploration has been questioned, since up to 50% of patients with a negative second look show recurrences within two years (1).
The Clinical Relevance of Neopterin in Prognosis of Women with Ovarian Cancer after Second Look Laparotomy
A total of 79 patients were included in the study. Of the patients who underwent second look laparotomy 60% were free of disease, 30% had residual tumor < 1 cm , 10% had tumor> 1 cm. The mean survival of patients with no evidence of disease was 57.5 months. The survival of women with a disease status of < 1 cm and > 1 cm was 44.0 and 12.8 months, respectively.
To study the prognosis of women after second look laparotomy the biological markers neopterin and CA 125 were studied (2,3).
Abstracts: Tenth Winter Work shop on Pteridines
Concentrations of neopterin and CA 125 determined at the time of second look were significant predictors of survival after the second look operation (p < 0.0001).
I n order to investigate if the predictive values of neopterin and CA 125 were independent from the results obtained at second look procedures. a subdivision of the patients according to the surgical findings at second look was performed . For neopterin, an association of high concentrations with unfavourable life expectation after second look was found in women with either no tumor or small « 1 em) tumor residuals.
An analysis of CA 125 on the same basis did not reveal any prognostic information.
Thus, neopterin might be used to differentiate the prognosis of patients after secondary procedures.
Serum Neopterin -Possible Marker to Predict Progression of Dilated Cardiomyopathy
M. Samsonov, E. Nasonov, V. Masenko , Y. Naumov, V. Mareev and Yu. Belenkov All-Union Cardiology Research Centre, Moscow, USSR Dilated cardiomyopathy (DCMP) is a heart muscle disease of unknown origin which is usually characterized by progressive heart failure with poor prognosis and fatal complications. It was proved that the development of pathological process in DCMP is accompanied with pronounced disturbances of immunity. In some patients with DCMP there were observed laboratory features of activation of the immune system such as ra ised serum neopterin and beta-2-microglobulin levels . On the other hand numerous clinical studies have shown that increased neopterin concentrations are associated with poor prognosis in pts with AIDS, cancer.
The aim of this study was to elucidate the possible prognostic significance of serum neoopterin levels (SNL) in DCMP patients. 15 pts with clinical diagnosis DCMP (14 males, 1 female, mean age 35 +-3 years, NYHA class 11-1 V) were clinically assessed and followed up from 3 to 24 months (mean follow-up 121 period was 11 ± 7 months) . SNL was measured by RIA (Henning-Berlin. Germany). According to clinical course of DCMP pts during follow-up they were divided into 2 groups (gp): I-stable (5 pts) or impro\'ed (2 pts): II-deterioration (3 pts) or death (:; PI;;) .\ 1 1 pts were at comparable therapy. Mean l\iYHA -:1<1:-. ' at the beginning of the study was 2.4 ± 0.9 in I gp and 2.8 ± 0.8 in II gp (p = NS).
The mean baseline SNL in I gp was 10.3 ± 3.2 nM / L and in II gp -12.09 ± 1.8 nm / L (p = NS). However, the mean SNL was significantly higher in II gp (18.02 ± 2.7 nM / L) than in I gp (7,0 ± 0.6 nM / L) at the end of the study (p < 0.01) .
Also, unfavourable clinica l course was associated with increase of SNL during tte follow-up measurement.
Conclusion
The increase of SNL in DCMP pts during follow-up may predict bad outcome . 5), reflecting hi gh activation of the M0 system . Also, if correlated to high serum creatinin e levels, the differences were still significa nt. In PBM C cultures, the y-IFN induced NPT synthesis profiles were normal per single M0 except in th e ea rly phase after severe trauma (p > 0.(5). In parallel , ILl and IL-S release after severe trauma (p > 0.05) . In pa rallel, IL-l and IL-8 release was significantly impaired after accidental o r mec ha nical trauma . I L-6, a pote nt inductor of the acute phase reaction, was high after trauma and in sep tic sta tes (19.6 x 1000 Units/ ml supernatant , control: 9.4 ± 1.5 Ul ml, p < 0.05).
Comparison of Neopterin Synthesis and Monokine
I n septic patients (n = 9) and controls, FcR + mo nocytes NPT synthesis was significantl y lower th a n in FcR -monocytes (control 8.9 ± 2.S nmoll l vs. 18.9 ± 2.9 in FcR -mo nocy tes, p < 0.(5). IL-6 release, however, was elevated in FcR + cells.
The results of thi s stud y show, that there is a differential influence of traum a o n M0 function a l activity in sepsis and after tra um a, with a deficit in forwa rd reg ulatory monokines (I L-l , IL-S), whereas IL-6 synthesis profiles (acute phase induction) were hi gh in the same cell cultures. Assessment of NPT synthesis rates are of importa nce to get further insight in unspecific metabolic activity of M0 after trauma a nd in sepsIs. Neopterin analysis was shown to be a useful tool to aid diagnoses of inflammatory disorders in postmortem examinations [1] . Interes tingly serum neopterin and creatinine concentrations increased significantly during time after dea th [2] .
Serum Neopterin and Tryptophan Changes after
We examined whether in vitro production ofneopterin ca n be observed in freshly co llected whole blood sa mples. In addition, we performed serial measurements of neopterin, creatinine, tryptophan and kynurenine in 6 corpses by HPLC. All persons died an unexpected and sudden death without any signs of inflammatory organic disorders. Samples were taken within 3 and 33.5 hours after death by puncturing the V. femorali s after in situ preparatio n. In 5 cases autopsy was performed before sample collection, in 1 case after sa mple collection .
N ine of 10 samples of hea lth y subjects showed hi gher neopterin concentratio ns after incubation for 24 hours (6 .S ± 1.13 nmol / L) co mpared to baseline (6.3 ± 1.06 nmol / L; 7 = 2.21 , p = 0.03; Wilcoxon paired ra nk sum test). However, thi s small relative increase cannot ex plain the significa nt time-dependent increase of serum neopterin, which is sometimes more th a n 5-fold in corpses. In S cases, in whom autopsy was performed before sa mpl e collection , we found rather stable or even declining neopterin levels. In contrast, a n increase of neo pterin was observed, when auto psy was performed after sampling (case 6) reaching 163 % of the baseline level after 21 hours. Tryptopha n showed decreasing trend with incrasing time after death in cases 1 -5, wherea s in case 6 an increase of tryptophan was o bserved. In all cases kynurenine levels either decreased o r remained nearly sta ble around baseline. An increase of serum creatinine was o bserved in a ll cases. Autopsy appears to influence postmortem neopterin and tryptophan metabolism in humans, whereas creatinine remains indifferent. Further studies are needed to elucidate possible immunological processes involved in changes of serum neopterin and trypto phan after death. Congenital pure red cell anemia (PRCA: DiamondBlackfan Syndrome) is a rare disease . The clinical signs become appa rent in infancy. The most characteristic diagnostic sign is an aplastic anemia with a deficiency of only red cell precursors in the bone marrow. It has bee n suggested that some patients of PRCA may suffer an abnormality of tryptophan metabolism (1) .
We have examined a boy with PRCA from when he was 1 year-old until age 14. His peripheral T cells inhibited the differentiation of autologous stern cells the erythroid cells in stem cell assay. His PRCA was active when he was 3 year-old until age 12. But when he was 13 year-old he received an immuno-suppresive therapy by Predisolone and Mizoribin. Since this therapy brought about a remission in his case, these medicines have been continuously administered after that. In this study his serum and urinary levels of neopterih and tryptophan metabolites (kynurenin, 3-hydroxykynurenin, Xanthurenic Acid. Kynurenic Acid . 3-hydroxyanthranilic Acid) were determined. Serum levels of these increased in the T cell related pure red cell anemia. These metabolic changes might be caused by increased interferon-y (2).
Urinary neopterin jcreatinine ratio is knO\\n to be a good marker for the indication of acute allograft rejection after liver transplantation (1) . but it gi\es poor information for the discrimination of an acute allograft rejection and various infections. Therefore we estimated the amount of neopterin in human bilc fluid in order to gain a more specific parameter for this differential diagnosis. Biliary neopterin was measured by means of a commercially available radioimmunoassay, and spot checks of every tenth sample were performed with HPLC (2).
In the present study we determined biliary and urinary neopterin levels during the post-operative course of nine patients after orthotopic liver transplantation. We found that elevation of biliary neopterin levels in case of an acute allograft rejection occurs one day after enhancement of urinary neopterin concentrations. A successful thcrapy of acute allograft rejection results in a prompt reduction of biliary neopterin 123 concentration which is faster than the decrease of urinary neopterin /creatinine ratio . If an acute allograft rejection does not respond to an immune-suppressive therapy. biliary as well as urinary neopterin levels remain elevated. Both parameters are good indicators for the short time prognosis after liver transplantation. In contrast to urinary neopterin biliary neopterin concentration is not increased in the case of several viral infections, i. e. CMV. hepatitis B, non-A, non-B hepatitis and herpes simplex.
Based on our observations we assume that biliary neopterin concentration is more specific for the diagnosis of an aeute liver allograft rejection than urinary neopterin/creatinine ratio. Biliary neopterin is a prominent parameter for the differential diagnosis of acute allograft rejection and viral infections after liver transplantation. Therefore we recommend to determine biliary as well as urinary neopterin in these patients in order to gain good discrimination of these complications following liver transplantation. Seventeen patients with chronic non-A/ non-B hepatitis were part of a randomized controlled study of interferon-(fFN )-ex-2b treatment: 12 suffered from chronic actiw hepatitis, 5 had chronic persistent hepatitis. All received 3 million units IFN-ex three times weekly for 36 weeks. Serum samples were collected at baseline. 4 and 36 weeks after start of therapy and 24 weeks after treatment (60 weeks from start of therapy). Serum neopterin, J32-microglobulin (B2M) and I FN-y were measured by commercially available radioimmunoassays (Henning, Pharmacia. Centocor).
Eight of 17 (47%,) patients had increased neopterin levels at baseline (median: 8.4 nmol / L) compared to healthy blood donors; B2M was elevated in 3 (18%; 1.9 mg/ L) and IFN-y was increased in 10 patients (59%; 139 U / L) . During therapy neopterin and B2M levels increased (neopterin: median at wk4 17.2, p = .002, Wilcoxon paired rank test; wk36 11A, p = .02; B2M : wk4 2.2, p = .004; wk36 2.4, p = .002); I FN-y decreased (wk4 61, P = n. s.; wk36 81, P = .04).
At wk60 all three marker concentrations were no longer different from baseline (p > .1).
At baseline neopterin and B2M levels correlated with IFN-y (rs = .60, P = .02 and rs = .40, P = .11), degree of correlation was low (e. g. wk36 rs > .1) during therapy, it increased in wk60 (neopterin: rs = .33 , p = .19). The correlation between neopterin and B2M behaved differently: baseline rs = 0.49, P = 0.05); wk rs = .79, p = .002; wk36 rs = .61 , P = .01; wk60 rs = .66, p = .008).
In vitro, human macrophages produee and release large amounts of neopterin on stimulation with IFNy. The data obtained in patients with non-A/ non-B hepatitis indica te that elevated neopterin at baseline can be referred to endogenously released IFN-y. During treatment with IFN-cx.-2b the correlation between neopterin and IFN-y is lost, however the correlation between neopterin and B2M becomes stronger. This indicates that neopterin and B2M are induced by exogenous IFN-a during treatment. Also the in vitro formation of neopterin by human macrophages is modified by IFN-c>: and other cytokinines. Decreasing IFN-y levels during therapy may indicate decreasing cellular immune activation due to reduced virus reproduction as is reflected by improving liver function tests . A close communication of APC (antigen presenting cells) and T cells via surface molecules is required for antigen (Ag)-specific activation of T cells [1] . Update concepts of Iymphology view the lymphatic system more broadly in terms of an integrated "blood-lymph loop" [2] .
Urinary Neopterin in
KS , and in a larger sense AIDS/ KS itself, may be considered a disorder of the lymphatic system. In patients with KS alone, even AIDS/ KS , we can find low neopterin levels suggesting a not continuous "priming" of MM perhaps due to an altered communication between APC and T cells (impaired lamphatic function or drainage?) but also suggesting a "functional reserve" for "primed" MM.
On the other hand, a continous activation of these types of cells, as suggested by the constantly raised neopterin and kynurenine levels found in haemophiliac patients, could give to the host organism a better resistance to Kaposi's sarcoma (KS) and /or other "opportunistic" neoplasias development, but also makes these cells unable in time (exhaustion?) to interrupt the replication of the obligate intracellular pathogens in HIV + individuals [3] . The simultaneous analysis of neopterin (as index of monocytes "priming") and kynurenine excretion (as index of "fully activated cells") could given further information. Naturally occuring oxidised neopterin urinary levels were measured by HPLC method in our laboratory and the results were expressed as the ratio of neopterin to concurrent urinary creatinine concentration.
These data show the interest of this marker against parameters currently used in the immune status evaluation of these patients (CD4 + and CD8 + T cells. We observed an early and intense raise of ncopterin when opportunistic infections occur (especially cerebral toxoplasmia and CMV septicemia) which is of great interest to begin rapidly appropriate therapy.
In the panel of the parameters evaluated , neopterinuria and ~2 microglobulinemia are the best correlated (Spearman' s coefficient = 0,56).
We also report our prospective follow-up to know if neopterin levels are able to determinate which seropositive individuals would further develop clinical AIDS. / L , stage CDC-IVC2) prior to therapy and on a daily basis during the first week, after treatment with Zidovudine (5 x 250 mg/d) was initiated. Neopterin concentrations in ea rly morning urine samples were related to urine creatinine concentrations. Baseline neopterin levels were 694, 743, and 1177 ~mol / mol creatinine. After start with Zidovudine, neopterin increased in a ll patients reaching peak levels at days 1 -3 (122 -143 % of pretreatment values). Thereafter neopterin levels declined in all patients reaching 304, 385, and 526 ~mol jmol creatinine (44 -52% of pretreatment values) .
Neopterin levels dropped drastica lly within seven days after Zidovudinc \\'as administered. An initial rise of neopterin was oh~c("\ed \\hich renders unlikely that Zidovudine direct ly rcduc,> Il -:,'r tcrin fo rmation. Within the friend ship contract between the Tyrolean government and the region around Resita in southwest Romania (chair: 1. Kohler) we are providing medical care for an orphanage in Resita whose residents are three years of age and under. In addition to medical support and education, and exchange of medical subspecialists, we intended to improve the standards of medical care and hygiene. Human immunodeficiency virus type 1 (HIV -1) has obviously been spread between infants of Romanian orphanages by transfusion of untested blood. In conjunction with the local medical office in Caras Severin we have collected blood samples from all 135 orphans (3 -40 months of age) and female staff members (n = 11) in November 1990. Sixty-nine infants (51.1 0 0 ) \\cre found HIV -1 a ntibody seropositive (H I V-+-) h :-ELISA (Abbott) and Western blot; two had a ~tr l)]1~I : positive ELISA-result but were questionable by \\ c< -ern blot. All sta ff me mbers were seronega!i\c . Dc:-tailed ph ysical examinations and medical histl) ri-: , were obtained which showcd a mixture of SYIl1l'l l) -matic (P-2) and asymptomatic (P-l) HIV + infan!~, Our preliminary data have identified neopterin level as a valuable laboratory based discriminator of HIV related illness in addition to clinical parameters which can easily be applied to other third world settings with a similar mix of HIV and non-HI V related illnesses. 72 sera showed antibodies for at least one HIV antigen. 9 sera (8 men, 1 woman; mean age 30 years) confirmed seropositivity by a\1 bands. Two of them had clinically syptoms (1 Kaposi's sarcoma, 1 lymphadenopathy); 2 were tested in health care institutions (1 pregnant, 1 in preoperative period), 1 homosexual, 1 registered in STC clinic, 1 sexual contact of HIVinfected person , 2 anonymous. We supposed all of them acquired the infection through sexual contact (2 of them are homosexuals, 6 bisexual men, 2 have had syphilis) .
Epidemiology of "IV -1 infection in Lithuania
Western blot used as confirmatory test left a number of unclear cases . 63 sera are considered with indeterminate Western blot. In 32 cases there were found antibodies to one HIV-antigen, 23 had two, and 8 had three reactive bands.
Alternative tests like immunofluorescence or polymerase chain reaction (PCR) are required. We are also interested to test for neopterin levels to predict prognosis in HIV -seropositives .
